FIGS Q3 2026: A Stitch in Time for Growth, Margin Shaves, and a Broader International Lift

Reporting in the voice of a veteran finance scribbler, with a nod to EPS, revenue forecasts, and the hard-to-ignore reality of earnings dynamics. FIGS is the ticker to watch on NYSE, and the quarter offers more than just color-coordinated scrubs.

FIGS, Inc. (NYSE: FIGS) delivered third-quarter 2026 results that show the company moving with purpose on top-line growth while navigating the subtle friction of margins and costs. The press release highlights a quarterly revenue surge and a stronger profit contribution, but the real story may be how resilient the growth engine remains as the company chases a broader international footprint.

Key metrics at a glance

Net revenues: $190.7 million, up 25.7% year over year.
Net revenues by segment: Scrubwear $157.5 million (up 24.0% YoY); Non-scrubwear $33.2 million (up 34.6% YoY).
Geographic mix: U.S. net revenues $153.9 million (up 20.8% YoY); International net revenues $36.8 million (up 51.4% YoY).
Gross margin: 69.3% (down 60 basis points YoY).
Operating expenses: $109.9 million, up 13.9% YoY, but as a percentage of net revenues, declined to 57.6% from 63.6% a year ago.
Net income: $19.3 million, or $0.10 per diluted share, up from $8.7 million ($0.05 per diluted share) in the prior-year period.
Net income margin: 10.1% (vs. 5.8% in the prior-year period).
Adjusted EBITDA: $31.5 million.

The company also noted that it published a financial highlights presentation on its investor relations site. This is the sort of deck that makes you want to check the MAP (margin, accretion, and profitability) as you skim for the ripple effects on the stock’s multiple.

Analysis: what’s driving the numbers and what’s not

The revenue story isn’t a mystery: SCRUBWEAR remains the growth engine, with international expansion outpacing the U.S. growth rate. The 51.4% YoY international uplift suggests that FIGS’ international go-to-market efforts, distribution partnerships, or perhaps favorable pricing in non-U.S. markets are starting to bear fruit. The U.S. market, while still the largest contributor, is growing at a more modest pace, which is departments- and procurement-budget friendly for a consumer brand tethered to a specific professional audience.

Gross margin at 69.3% is healthy, but the 60 basis point decline year over year flags a couple of pressure points. The company attributes it to outsized improvements in returns processing in the prior year and higher inventory reserves, with offsetting tailwinds from pricing actions and ongoing efficiency efforts. In other words, FIGS appears to be dialing in its pricing discipline and cost-control levers, even as returns and reserve dynamics chip away at the margin line.

On the expense side, operating expenses rose 13.9% YoY, yet as a share of net revenues they receded, indicating meaningful fixed-cost leverage. The implication is straightforward: as top-line growth continues, the company seems to be extracting more operating leverage—an encouraging sign for margin expansion in future quarters if revenue momentum persists.

The quarterly result lines up with a solid year-over-year recovery in profitability: net income increased to $19.3 million and diluted EPS touched $0.10, doubling the prior-year EPS of $0.05. The company also reported a strong Adjusted EBITDA of $31.5 million, which provides some cushion for investors evaluating cash-generation strength separate from accounting peculiarities.

One important caveat for readers: the press release excerpt does not provide a formal comparison against an external EPS consensus or any explicit “earnings surprise” metric in the quarter. Analysts will likely weigh this quarter against their own EPS consensus estimates and revenue forecast for FIGS to gauge whether the quarter qualifies as a surprise or a met expectation. In the absence of a stated surprise in the release, the market’s read will hinge on how the company’s guidance and ongoing margin trajectory align with forward views.

Outlook and strategic implications

The company signaled an increasing full-year 2026 outlook, a move that suggests management is confident in sustaining the revenue trajectory and leveraging operating leverage to support profitability. For readers and investors, that implies a revenue forecast that supports higher EBITDA contribution and a potentially more durable margin profile, assuming the mix between Scrubwear and non-scrubwear remains favorable and returns dynamics don’t re-accelerate.

In a sector where product quality, direct-to-consumer reach, and international expansion matter, FIGS’ Q3 performance reinforces the idea that the broader healthcare apparel space can deliver meaningful top-line advances even as margins compress from period to period. The takeaway for sector peers is subtle but important: growth in international markets, disciplined pricing, and cost leverage can coexist with margin pressure from one-off reserve adjustments and returns dynamics. The balancing act will be whether peers can replicate FIGS’ mix shift while preserving or expanding gross margins over time.

What this could portend for peers and the industry

For FIGS’ peers in healthcare apparel and direct-to-consumer medical wear, the Q3 narrative highlights a few durable themes: a) international growth still has legs, b) pricing power can support margin resilience, and c) returns management and inventory discipline are live issues that can influence reported margins meaningfully.

Investors will likely scrutinize how FIGS translates the Q3 revenue momentum into sustained profitability, testing whether the company can keep the 20%–plus revenue growth in the face of competitive pressure and potential promotional noise. The EPS trajectory—now at $0.10 per share for the quarter—will be juxtaposed against consensus expectations to determine if the result is a genuine earnings surprise or a solid beat relative to forecasts.

For sector peers, the big question is whether the current environment—tightening consumer demand for professional wear paired with ongoing e-commerce expansion—permits a broader multiple expansion. If FIGS can move the margin needle higher over the next several quarters while continuing to scale international revenue, it would suggest a consolidating premium for brands that combine specialty appeal with scalable distribution.

Bottom line

FIGS’ Q3 2026 results illustrate a company that is growing robustly in revenue while making measured strides on profitability. The combination of solid top-line gains, a favorable international tilt, and continued cost discipline offers a blueprint for how growth and margins can cohabit in a hyper-competitive niche. As analysts parse EPS consensus and revenue forecasts for the next quarter and the full-year outlook, FIGS remains a name to watch for both its direct-to-consumer discipline and its ability to translate fast growth into durable earnings power.